Healio10h
‘Coming to the clinic soon’: Top AAD takeaways from Joel M. Gelfand, MD, MSCE
The American Academy of Dermatology annual meeting was packed with “massive advancements” across the field, Joel M. Gelfand, ...
European Medical Journal11h
Why Diversity in Clinical Trials Matters More Than Ever
Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...
Dermatology Advisor14h
Dermatologists’ Knowledge Regarding Lichen Planus Treatment May Be Lacking
Acitretin, isotretinoin, and ultraviolet B are less frequently used than other class I treatments for lichen planus, such as topical corticosteroids.
Dermatology Advisor14h
Guselkumab Substantially Improves Fingernail Psoriasis
More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.
The American Journal of Managed Care16h
Deucravacitnib Improves Quality of Life in Patients With Scalp Psoriasis
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...
Sensus Healthcare price target lowered to $13 from $18 at Lake Street
Lake Street analyst Ben Haynor lowered the firm’s price target on Sensus Healthcare (SRTS) to $13 from $18 and keeps a Buy rating on the shares ...
Healio17h
‘Landmark’ study shows potential of ruxolitinib cream 1.5% for prurigo nodularis
Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...